For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

Supporting our customers and employees during the COVID-19 pandemic. Read more

The nuclear receptor super family

Related

By Claudie Hooper (Kings College London) *​​

Read about nuclear receptors' mechanism of signaling and structure.

​[Please note, this page is no long updated] 


Contents

1. Introduction to nuclear receptors and sub-classification of the super family​

2. Nuclear receptors and mechanisms of signaling

3. Nuclear receptor structure


​

​

1. Introduction to nuclear receptors and sub-classification of the super family

Nuclear receptors play many important roles in eukaryotic development, differentiation, reproduction and metabolic homeostasis (Ribeiro et al.,1995; Bain et al., 2006). Proteins of the nuclear receptor super-family are single polypeptide chains with three major domains: a variable amino-terminal domain, a highly conserved DNA-binding domain (DBD), and a less conserved carboxyl-terminal ligand binding domain (LBD). The superfamily is sub-divided into three classes. Class 1 is the steroid receptor family, and includes the progesterone receptor (PR), the estrogen receptor (ER) (Figure 1), the glucocorticoid receptor (GR), the androgen receptor (AR) and the mineralocorticoid receptor. Class 2, or the thyroid/ retinoid family, includes the thyroid receptor (TR), vitamin D receptor (VDR), the retinoic acid receptor (RAR) and the peroxisome proliferator-activated receptor (PPAR). The third class of nuclear receptors is known as the orphan receptor family. This class of nuclear receptor comprises a set of proteins sharing significant sequence homology to known nuclear receptors, but for which the ligands have not yet been identified. Orphan nuclear receptor offer a unique system for the discovery of novel signaling pathways that could provide new drug targets for the treatment of a variety of human diseases.

​​Figure 1: Western blot of the estrogen receptor a

Expression of exogenous estrogen receptor a (ERa) in HEK293a cells.


2. Nuclear receptors and mechanisms of signaling

All nuclear receptors modulate gene transcription, although amongst the three classes there are differences in the mechanisms through which this is achieved (Ribeiro, 1995; Aranda and Pascual, 2001; Bain et al., 2006). Ligands for nuclear receptors circulate in the body bound to plasma proteins. Following dissociation from these proteins the ligands enter cells and bind to their receptors. Steroids and vitamin D probably enter cells through passive diffusion, whereas thyroid hormone and retinoic acid might gain cellular entrance via specific transport processes. 

Steroid receptors are bound to Hsps, such as Hsp90 and Hsp70, in the cytoplasm. Upon binding ligand, the free receptors then translocate to the nucleus and bind as homodimers to imperfect palindromic response elements at upstream promoter sites. DNA binding is coupled to the recruitment of transcriptional co-activators such as the p160 family (Xu and Li, 2003). Nuclear receptors can in some instances repress gene expression in a ligand-dependent manner, and in some cases promote gene transcription.

The class 2 nuclear receptors typically function as heterodimers. TR, VDR, RAR and PPAR associate with the retinoid X receptor (RXR) and bind as a dimeric complex to direct repeat response elements (Ribeiro, 1995; Aranda and Pascual, 2001; Eckey et al., 2003; Bain et al., 2006). The heterodimers are bound to their response element regardless of whether ligands are present and in the absence of heat shock proteins. Gene activation is suppressed by co-repressors such as silencing mediator for retinoic acid and thyroid hormone receptors (SMRT) and nuclear co-repressor (NCoR). Co-repressors are displaced by ligand binding allowing transcriptional activation to take place (Collingwood et al., 1999).

​

3. Nuclear receptor structure

A typical nuclear receptor consists of a variable NH2 terminal region (the A/B domain) and a highly conserved DNA-binding domain (DBD or C domain) (Tata, 2002; Robinson-Rechavi et al., 2003; Bain et al., 2006). The DBD contains a P-box, which is a short motif responsible for DNA-binding specificity and is involved in dimerization of nuclear receptors including the formation of both heterodimers and homodimers. The elucidiation of the 3D structure of the DBD reveals the presence of two zinc fingers. 

A linker region known as domain D is situated between the DBD and the ligand binding domain. This region functions as a flexible hinge and contains the nuclear localization signal. Phosphorylation of the hinge region is coupled with increased transcriptional activation. The ligand binding domain (LBD or E domain) is responsible for the binding of cognate ligand or hormone. This domain also contains a ligand-regulated transcriptional activation function (AF-2) necessary for recruiting transcriptional co-activators, which interact with chromatin remodeling proteins and the general transcriptional activation machinery. Most nuclear receptors contain an amino acid sequence N-terminal to the DBD in the variable A/B domain, which contains a transcriptional activation function known as AF-1. In contrast to the moderately conserved AF-2, the AF-1 shows weak conservation across the nuclear receptor super-family and may mediate differential promoter regulation in vivo. The AF-1 sequence functions as a ligand-independent transcriptional activator, but can also functionally synergize with AF-2. In addition to the domains described above some receptors contain a carboxyl-terminal region (F domain) of unknown function.​

Figure 2: Nuclear receptor structure​

Proteins of the nuclear receptor super-family are single polypeptide chains consisting of three major domains: a variable amino-terminal domain, a highly conserved DNA-binding domain (DBD), and a less conserved carboxyl-terminal ligand binding domain (LBD). AF: activation function (domain 1 and 2). H: hinge. Mutations in the nuclear hormone receptors lead to a variety of inherited disorders. Mutations in X-linked ARs result in testicular feminization syndrome with androgen unresponsiveness or hypo-responsiveness. Glucorticoid resistance and hereditary vitamin D resistant rickets are rare autosomal recessive disorders linked to mutations in the LBD or the DBD of the GR or the VDR respectively (Ribeiro et al., 1995).



​

References


Aranda A., Pascual A. (2001) Nuclear hormone receptors and gene expression. Physiolog. Rev. 81, 1269-1304.

Bain D. L., Heneghan A. F., Connaghan-Jones K. D., Miura M. T. (2006) Nuclear receptor structure: implications for function. Ann. Rev. Physiol. 69, 9.1-9.2.

Collingwood T. N., Urnov F. D., Wolffe A. P. (1999) Nuclear receptors; coactivators, corepressors and chromatin remodelling in the control of transcription. J. Mol. Endocrinol. 23, 255-275.

Chekis B. J. (2004) Regulation of cell signalling cascades by steroid hormones. J Cell Biochem. 93, 20-27.

Eckey M., Moehren U., Baniahmad A. (2003) Gene silencing by the thyroid hormone receptor. Mol Cell Endocrinol. 213, 13-22.

Ribeiro R. C. J., Kushner P. J., Baxter J. D. (1995) The nuclear hormone receptor gene superfamily. Annu. Rev. Med. 46, 443-453. 

Robinson-Rechavi M., Garcia H, E., Laudet V. (2003) The nuclear receptor superfamily. J. Cell Sci. 116, 585-586. 

Tata J. R. (2002) Signaling through nuclear receptors. Nat Rev. Mol Cell Biol. 3, 702-710.

Xu J., Li Q. (2003) Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol.17, 1681-1692.




Dr Claudie Hooper

Department of Neuroscience, Institute of Psychiatry, Kings College London, Denmark Hill, London, SE5 8AF.
E-mail: c.hooper@iop.kcl.ac.uk 
Tel: +44 (0) 207 8485245





Get resources and offers direct to your inbox Sign up
A-Z by research area
  • Cancer
  • Cardiovascular
  • Cell biology
  • Developmental biology
  • Epigenetics & Nuclear signaling
  • Immunology
  • Metabolism
  • Microbiology
  • Neuroscience
  • Signal transduction
  • Stem cells
A-Z by product type
  • Primary antibodies
  • Secondary antibodies
  • Biochemicals
  • Isotype controls
  • Flow cytometry multi-color selector
  • Kits
  • Loading controls
  • Lysates
  • Peptides
  • Proteins
  • Slides
  • Tags and cell markers
  • Tools & Reagents
Help & support
  • Support
  • Make an Inquiry
  • Protocols & troubleshooting
  • Placing an order
  • RabMAb products
  • Biochemical product FAQs
  • Training
  • Browse by Target
Company
  • Corporate site
  • Investor relations
  • Company news
  • Careers
  • About us
  • Blog
Events
  • Tradeshows
  • Conferences
International websites
  • abcam.cn
  • abcam.co.jp

Join with us

  • LinkedIn
  • facebook
  • Twitter
  • YouTube
  • Terms of sale
  • Website terms of use
  • Cookie policy
  • Privacy policy
  • Legal
  • Modern slavery statement
© 1998-2022 Abcam plc. All rights reserved.